PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) today announced the appointment of Hiroaki Shigeta to the Company’s Board of Directors. Mr. Shigeta has a distinguished 40-year career leading international affiliates of global pharmaceutical firms.
